← Return to AML, age 78, taking Decetabine/ Venetoclax, no transplant
DiscussionAML, age 78, taking Decetabine/ Venetoclax, no transplant
Blood Cancers & Disorders | Last Active: Jun 1 9:47am | Replies (80)Comment receiving replies
Replies to "@loribmt I echo the comments of others in thanking you for posting and your guidance on..."
Connect

Good morning @sonieaml
Earlier this month (May 2026) the FDA approved INQOVI in combination with Venetoclax, for the first all-oral combination treatment for patients (75 yrs of age) or, patients with AML who aren’t eligible for intensive chemo. In the trial, treatment with INQOVI (which is decitabine/cedazuridine) plus Venetoclax yielded a complete remission (CR) rate of 41.6% and a CR rate of 52.5% in patients ineligible for intensive induction chemotherapy. That’s impressive!
There have been some really promising breakthroughs over the past few years for us folks over 70!
I did a quick search to see mentions of other members taking INQOVI for MDS or AML. Here’s a link to the search:
https://connect.mayoclinic.org/search/
It’s fantastic news that you’re showing no evidence of the FLT3 or NPM1 mutations!! FLT3 can be a bad actor! So I’m thrilled for you! The V & D regime has worked! Wishing you continued success as you transaction to the INQOVI. It looks to be another promising drug!
Thank you again for sharing your journey all along with us. It brings hope and inspiration to AML Warriors! ☺️
Have you been able to stop taking the venetoclax and dacogen for now?